PPIA and cardiovascular disorder: Similar to cyclophilin A (CypA), extracellular CypB has been demonstrated to increase in response to inflammatory stimuli and oxidative stress (18), and serves as a serum biomarker in several inflammatory diseases, such as acute lung inflammation, rheumatoid arthritis, Sjögren’s syndrome, and cardiovascular disease (8).